[Infectious diseases: Achievements, new Developments and Perspectives in 2021].

Autor: Blondet F; Département de médecine, Ensemble hospitalier de la Côte, 1110 Morges., Aebischer O; Département de médecine, Ensemble hospitalier de la Côte, 1110 Morges., Tusgul S; Département de médecine, Ensemble hospitalier de la Côte, 1110 Morges., Monsalve Arteaga L; Département de médecine, Ensemble hospitalier de la Côte, 1110 Morges., Schaad N; Pharmacie interhospitalière de la Côte, Ensemble hospitalier de la Côte, 1110 Morges., Challet C; Pharmacie interhospitalière de la Côte, Ensemble hospitalier de la Côte, 1110 Morges., Doser N; Département de médecine, Ensemble hospitalier de la Côte, 1110 Morges., Sedda A; Département de médecine, Ensemble hospitalier de la Côte, 1110 Morges., Urbano L; Département de médecine, Ensemble hospitalier de la Côte, 1110 Morges., Marchetti O; Département de médecine, Ensemble hospitalier de la Côte, 1110 Morges.
Jazyk: francouzština
Zdroj: Revue medicale suisse [Rev Med Suisse] 2022 Feb 02; Vol. 18 (767), pp. 173-181.
DOI: 10.53738/REVMED.2022.18.767.173
Abstrakt: The substantial progresses during the last decades in the field of infectious diseases have significantly improved their prevention, diagnosis and treatment. Basic and medical sciences have efficiently dealt with the challenges of emerging infections, infectious complications related to the increasing complexity of medical practices and marked slow-down in the development of new antimicrobial agents. During the worldwide crisis related to the COVID-19 pandemic, the « medical normality » has been put in stand-by, but medical advances have fortunately continued. In the present article we present new knowledge in the field of bacterial, viral and fungal infections, which may modify hospital and ambulatory practices. Significant achievements in the field of COVID-19 will be presented in a future article.
Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
Databáze: MEDLINE